NCT07370974

Brief Summary

This Multicenter randomized controlled trial evaluates clinical hypnosis efficacy for reducing perioperative anxiety and postoperative pain in abdominal surgery patients across 3 Moroccan centers (n=48-68). Intervention arm receives 15-20 min level 2 hypnosis session preoperatively; control receives standard psychological preparation. Primary outcome: VAS-anxiety post-intervention. Secondary: postoperative EVA-pain, analgesic consumption, length of stay. Study Design Prospective, multicenter, parallel-group RCT (1:1 allocation, stratified by center/sex). Inclusion: consenting ASA I-II adults for abdominal surgery. Primary endpoint powered for 10mm EVA reduction (80% power, α=0.05). Registration supports PhD thesis at ISSS/Université Hassan 1er Settat.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 22, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 2, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

January 2, 2026

Last Update Submit

January 22, 2026

Conditions

Keywords

RCTMoroccoHypnosispreoperative anxiety

Outcome Measures

Primary Outcomes (1)

  • Preoperative anxiety

    Perioperative Anxiety (Primary Outcome) is measured using the Visual Analog Scale for Anxiety (EVA-Anxiété, 0-100 mm). Primary Outcome Measure: preoperative anxiety level Assessment Tool: 100-mm Visual Analog Scale (VAS-Anxiety): 0 mm = No anxiety ("Je ne suis pas du tout anxieux") 100 mm = Worst possible anxiety ("Anxiété maximale imaginable") Timepoints: (post-intervention, \~10 min later). Expected hypnosis effect: ≥10 mm reduction vs. control. Protocol Specifications Patient marking: Single horizontal 100-mm line; mark position indicates intensity Scoring: Distance (mm) from "No anxiety" (0) to mark, precise to 1 mm

    1 hour Before surgery

Secondary Outcomes (3)

  • Postoperative pain

    6 and 24 hours postoperatively

  • medication consumption

    Perioperative

  • length of stay

    Perioperative

Study Arms (2)

Fisrt arm: patients having a session of hypnosis prior to surgery

EXPERIMENTAL

Patients randomized to the intervention arm undergo a single 15-20 minute clinical hypnosis session preoperatively for anxiety reduction, achieving level 2 hypnotic trance (somnambulism)

Other: Clincal hypnosis

Arm 2 : patients will be treated as usual with standard conditions

NO INTERVENTION

Patients in this group will receive standard usual care without any hypnotic intervention, only with routine psychological preparation.

Interventions

Patients randomized to the intervention arm receive a single 15-20 minute individual clinical hypnosis session 30-60 minutes preoperatively. The standardized protocol includes: * Induction phase (3-5 min): Eye fixation, progressive relaxation breathing * Deepening phase (5 min): Level 2 somnambulistic trance achievement * Therapeutic suggestions (7-10 min): Anxiety reduction imagery, surgical calm visualization * Emergence phase (2-3 min): Safe awakening to alert consciousness Delivered by certified hypnotherapist using validated script for preoperative anxiety in abdominal surgery patients." Key Elements Required Timing: Preop holding area, 30-60 min before incision Provider: Trained clinician (specify certification) Dose: Single 15-20 min session Target: Level 2 hypnosis (somnambulism) Outcome link: EVA anxiety scale pre/post This matches your 3-center RCT design (\~16 patients/center, stratified randomization) and distinguishes from control arm (standard psychological preparation

Also known as: Hypnosis, hypnotism, Hypnosis session
Fisrt arm: patients having a session of hypnosis prior to surgery

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consenting patients undergoing abdominal surgery
  • ASA I-II physical status
  • Able to understand and respond to instructions
  • No major psychological disorders

You may not qualify if:

  • Non-consenting patients
  • Prior experience with hypnosis
  • History of mental illness
  • Psychoactive substance consumption
  • Cognitive disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kenitra, Rabat Sale Kenitra region, Morocco

Kenitra, Province, 14000, Morocco

COMPLETED

Settat, Casablanca settat region , Morocco

Settat, Province, 26000, Morocco

NOT YET RECRUITING

Youssoufia, Marrakech-Safi Morocco

Youssoufia, Province, 46300, Morocco

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • NAOUFAL HIMMOUCHE HIMMOUCHE, Professor

    Laboratory of health sciences and technlmogies, Higher Institute of Health sciences, Hassan Fisrt University, Settat Morocco

    STUDY DIRECTOR
  • YASSINE HAFIANI, Professor

    Pedagogical Unit of Anesthesia and Intensive Care, Rabat Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco

    STUDY DIRECTOR

Central Study Contacts

YOUSSEF EL-ALLAM EL-ALLAM, Phd student

CONTACT

NAOUFAL HIMMOUCHE Pr Himmouche, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study did not use any kind of masking or blinding,
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 2, 2026

First Posted

January 27, 2026

Study Start

December 22, 2025

Primary Completion

March 20, 2026

Study Completion

April 20, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Data sharing not planned. Individual patient data will not be shared due to:" Small sample size (n=60 across 3 centers) creates high re-identification risk in Morocco's healthcare context Patient consent forms obtained pre-NIH Policy 2.0 did not include data sharing provisions Doctoral thesis protocol approved by CERB Mohammed V Rabat without data sharing plan Local data protection regulations (Loi 28-13) limit identifiable health data transfer Resource constraints prevent data de-identification and controlled access infrastructure Summary results, statistical analysis plan, and blinded protocol available upon request to corresponding author post-publication.

Locations